Dr. Roberto A. Leon Ferre, MD

Dr. Leon Ferre practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Leon Ferre's NPI, 1427361377, was assigned on July 21, 2010. Dr. Leon Ferre graduated from Universidad Catolica de Santiago de Guayaquil in 2007. Dr. Leon Ferre's Minnesota license number on file is 57809.

Dr. Leon Ferre's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Leon Ferre's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Leon Ferre is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Leon Ferre to 1 more clinical lab and 1 hospice, each named with a free account. Dr. Leon Ferre's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leon Ferre practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Leon Ferre's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Leon Ferre is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Leon Ferre's licenses on file in 2 states: Minnesota and Iowa.

Dmand AI lists breast cancer, colorectal cancer, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Leon Ferre treats.

CMS data shows 60,063 Medicare services from Dr. Leon Ferre across 42 procedure codes in 2024, for 472 Medicare patients. Medicare paid $985,630 for them. Every service was in an office.

CMS counts 472 Medicare patients who saw Dr. Leon Ferre in 2024. The largest group is 65 to 74, with 255 patients. 63% of them have high blood pressure, and 58% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Leon Ferre's median patient age at 66, with 65% women.

In 2024, Dr. Leon Ferre wrote 328 Medicare Part D claims for 74 patients. 77% of them were for generic drugs. CMS names the drug for 259 of them, across 10 drugs with 11 or more claims each, at $760,258 in total drug cost. In 2023, CMS named 109 claims across 4 drugs.

Dr. Leon Ferre accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Leon Ferre as offering telehealth.

Dmand AI links 3 papers to Dr. Leon Ferre, published from 2017 to 2020. The most frequent topics are Anticoagulants, Dalteparin and Pyrazoles. Dr. Leon Ferre's most frequent co-authors are Aneel Arjun Ashrani, MBBS, Stanislav Henkin, MD and Charles John Lenz, MD.

Dmand AI links Dr. Leon Ferre to 5 clinical trials, 2 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Hot Flashes and Melanoma.

CMS Open Payments shows 28 general payments to Dr. Leon Ferre from 3 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 96% of the total. Gilead Sciences, Inc. paid the most, $17,292.

Dr. Leon Ferre graduated from Universidad Catolica de Santiago de Guayaquil in 2007. Dr. Leon Ferre is a member of ACP and ASCO.

Dr. Leon Ferre is in network with 15 carriers, including Aetna, Medica and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.